N-α,N-ε-di-Z-L-lysine

N-α,N-ε-di-Z-L-lysine is a protected lysine derivative bearing two benzyloxycarbonyl (Z, Cbz) protecting groups on the α-amino and ε-amino functionalities, with the remaining carboxyl group present as the free acid and the side chain retaining the characteristic (CH2)4 chain of lysine. The molecule contains both an α-carboxyl group and a protected α-amino group, while the ε-amino group is also carbamate-protected, and the "L" designation indicates the stereochemical configuration at the α-carbon. As a bis-carbamate-protected amino acid, it is employed as a stepwise building block in peptide synthesis where orthogonal control of amine reactivity is required, and the protected amines help suppress undesired side reactions during coupling and deprotection sequences.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP01463

CAS No:405-39-0

Synonyms/Alias:Z-Lys(Z)-OH;405-39-0;(S)-2,6-Bis(((benzyloxy)carbonyl)amino)hexanoicacid;N,N'-Dibenzyloxycarbonyl-L-lysine;SBB058133;N,N'-Bis(benzyloxycarbonyl)-L-lysine;N,N'-Di-Cbz-L-lysine;N2,N6-Bis[(phenylmethoxy)carbonyl]-L-lysine;L-Lysine,N2,N6-bis[(phenylmethoxy)carbonyl]-;(2S)-2,6-bis(phenylmethoxycarbonylamino)hexanoicacid;Nalpha,Nepsilon-Di-Z-L-lysine;(2S)-2,6-bis[(phenylmethoxy)carbonylamino]hexanoicacid;Cbz-Lys(Z)-OH;AC1OJJ91;N|A,N|A-Di-Z-L-lysine;KSC583G0T;96835_ALDRICH;SCHEMBL464715;N2,N6-Dicarbobenzoxy-L-lysine;96835_FLUKA;CTK4I3309;BLZXFNUZFTZCFD-IBGZPJMESA-N;MolPort-001-793-041;ZINC4521940;ANW-43412

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C22H26N2O6
M.W/Mr.
414.5

N-α,N-ε-di-Z-L-lysine is a protected L-lysine derivative bearing two benzyloxycarbonyl (Z, Cbz) groups at both the α-amino and ε-amino positions, yielding a diamine-protected amino acid with a stereogenic center at the α-carbon. The molecule retains the carboxylic acid functionality while masking both primary amines as carbamate-protected groups, which strongly modulates nucleophilicity and prevents undesired side reactions during peptide coupling. The Z carbamates are typically stable under many peptide synthesis conditions yet can be removed selectively by hydrogenolysis, enabling staged deprotection for orthogonal functionalization strategies. The resulting chiral, bis-protected lysine building block is well suited for constructing well-defined peptide sequences and for preparing downstream lysine-derived intermediates with controlled chemoselectivity.

1. Peptide Synthesis

N-α,N-ε-di-Z-L-lysine is applied in peptide synthesis workflows where lysine residues require orthogonal control of both the α- and side-chain amines. The α-carboxylic acid and the α-Z-protected amino group support standard amino-acid coupling chemistry, while the ε-Z carbamate protects the side-chain during chain assembly to minimize branching and cross-linking. Hydrogenolysis-based deprotection can be used to unmask the ε-amine after peptide elongation, enabling subsequent acylation, guanidylation, or further peptide fragment coupling. The bis-protected lysine structure therefore functions as a chiral, peptide-compatible intermediate for generating lysine-containing peptides and peptide analogs with defined side-chain substitution patterns.

2. Side-Chain Functionalization

N-α,N-ε-di-Z-L-lysine serves in side-chain functionalization programs that require controlled access to the lysine ε-amine after selective deprotection. The ε-Z carbamate masks the primary amine during initial synthetic steps, supporting sequential derivatization without premature reaction of the side chain. After removing the appropriate Z group(s), the liberated ε-amine can participate in forming amide linkages, urea/thiourea motifs, or other nitrogen-containing functionalities used to tune binding properties and molecular recognition. The protected lysine framework thus supports targeted amino acid derivatization and downstream synthesis of functionalized lysine-containing scaffolds used in chemical biology and materials-facing conjugation chemistry.

3. Bioconjugation Chemistry

N-α,N-ε-di-Z-L-lysine is suitable for bioconjugation chemistry where lysine-reactive handles must be introduced with controlled chemoselectivity. The presence of two Z-protected amines reduces nonspecific reactivity during intermediate preparation, allowing the compound to be carried through peptide or linker assembly steps before generating an amine-bearing conjugation site. Selective deprotection of the ε-amino carbamate can provide a defined nucleophile for coupling to activated esters, isothiocyanates, aldehydes, or other electrophiles commonly used to create stable amide or urea linkages. The chiral lysine backbone and protected-group strategy make the compound compatible with constructing conjugation-ready peptide fragments and linker modules for biomolecule labeling workflows.

4. Process Chemistry Intermediate

N-α,N-ε-di-Z-L-lysine is used as a manufacturing-oriented intermediate for producing protected lysine building blocks and peptide-grade components with predictable reactivity profiles. The bis-carbamate protection pattern suppresses amine-mediated side reactions during isolation, purification, and subsequent coupling steps, which can simplify downstream handling in fine chemical synthesis. The carboxylic acid functionality supports conversion into coupling-ready derivatives under controlled process conditions, while the Z groups provide a robust protection strategy that can be removed on demand to reveal lysine functionality. The compound's defined stereochemistry and stable protecting-group chemistry make it applicable to scalable routes for protected amino acid supply chains supporting peptide manufacturing and industrial chemical production programs.

5. Peptidomimetics And SAR Studies

N-α,N-ε-di-Z-L-lysine is applied in peptidomimetic construction and structure-activity relationship studies requiring lysine side-chain incorporation with controlled substitution. The protected ε-amine allows installation of side-chain modifications that can mimic post-translationally derived lysine states or introduce non-native functional groups while preserving the peptide backbone stereochemical integrity. Sequential deprotection and derivatization enable generation of libraries of lysine-modified analogs, including amide- or urea-containing variants that influence charge distribution and hydrogen-bonding networks. The compound therefore supports SAR-driven exploration of lysine-dependent binding motifs through chemically defined peptide analog synthesis and systematic amino acid modification strategies.

Abbr
Z-Lys(Z)-OH
InChI
1S/C22H26N2O6/c25-20(26)19(24-22(28)30-16-18-11-5-2-6-12-18)13-7-8-14-23-21(27)29-15-17-9-3-1-4-10-17/h1-6,9-12,19H,7-8,13-16H2,(H,23,27)(H,24,28)(H,25,26)/t19-/m0/s1
InChI Key
BLZXFNUZFTZCFD-IBGZPJMESA-N
Canonical SMILES
C1=CC=C(C=C1)COC(=O)NCCCCC(C(=O)O)NC(=O)OCC2=CC=CC=C2

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide CDMOCustom Conjugation ServicePeptide Synthesis ServicesPeptide Analysis ServicesEpitope Mapping ServicesPeptide Modification ServicescGMP Peptide ServicePeptide Nucleic Acids Synthesis
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers